The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
暂无分享,去创建一个
V. Quesniaux | M. Schreier | H. Schuurman | W. Schuler | J. Joergensen | C. Steiner | S. Wehrli | P. Herrman
[1] A. Marks,et al. Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line. , 1993, The Journal of biological chemistry.
[2] S. Schreiber,et al. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. , 1993, The Journal of biological chemistry.
[3] J. Blenis,et al. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase. , 1993, The Journal of biological chemistry.
[4] N. Sigal,et al. FK‐506–A Novel Immunosuppressant , 1993, Annals of the New York Academy of Sciences.
[5] P. Brûlet,et al. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation , 1993, Nature.
[6] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[7] E. Gelfand,et al. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle , 1993, Journal of cellular physiology.
[8] J. Pollard,et al. Delayed hematopoietic development in osteopetrotic (op/op) mice , 1993, The Journal of experimental medicine.
[9] D. Metcalf. The hemopoietic regulators – an embarrassment of riches , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.
[10] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[11] C. Stewart,et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.
[12] T. Hultsch,et al. The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines. , 1992, Molecular biology of the cell.
[13] V. Quesniaux,et al. Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. , 1992, Blood.
[14] C. Crews,et al. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[16] E. Gelfand,et al. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells. , 1992, Biochemical and biophysical research communications.
[17] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[18] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[19] N. Roehm,et al. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists. , 1992, The Journal of pharmacology and experimental therapeutics.
[20] T. Dexter,et al. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. , 1992, Blood.
[21] D. Dunlop,et al. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. , 1992, Blood.
[22] Y. Akselband,et al. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. , 1991, Transplantation proceedings.
[23] K. Rajewsky,et al. Generation and analysis of interleukin-4 deficient mice. , 1991, Science.
[24] D. Harrison,et al. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. , 1991, Blood.
[25] I. Horak,et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.
[26] A. Thomson,et al. Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. , 1991, Transplantation.
[27] R. Perlmutter,et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.
[28] L A Herzenberg,et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] O. Witte. Steel locus defines new multipotent growth factor , 1990, Cell.
[30] N. Iscove,et al. Precursors (pre-CFCmulti) of multilineage hemopoietic colony-forming cells quantitated in vitro. Uniqueness of IL-1 requirement, partial separation from pluripotential colony-forming cells, and correlation with long term reconstituting cells in vivo. , 1990, Journal of immunology.
[31] E. Wright,et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation , 1990, Nature.
[32] N. Sigal,et al. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. , 1990, Journal of immunology.
[33] N. Sigal,et al. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. , 1990, Journal of immunology.
[34] A. Shaw,et al. Net increase of pluripotential hematopoietic precursors in suspension culture in response to IL-1 and IL-3. , 1989, Journal of immunology.
[35] V. Chapman,et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.
[36] G. Cattoretti,et al. Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features , 1988, British journal of haematology.
[37] G. Hodgson,et al. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? , 1979, Nature.
[38] R. Morris. Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides , 1992 .